Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Yasser Abu Shabab's killing raises questions about Israel's militia strategy in Gaza - 2Misinterpretations and Mistakes Portrayed by Hollywood in the General set of laws
- 380 km. on foot: Sharren Haskel’s three-day march in protest of haredi draft bill
- 4Santa's sleigh or the International Space Station? How to spot a bright Christmas flyby Dec. 24 and 25
- 5Figure out How to Explore the Infotainment Framework in the Slam 1500.
- Addiction-stricken community struggles to keep a syringe program going after Trump's order
- Solid Living Tips: Experiences from a Wellness Fan
- 1st human missions to Mars should hunt for signs of life, report says
- Public Parks in the USA
- Audits of 6 Specialty Mixed drinks
- Nearly 16,000 New York City nurses prepare to strike as contract talks stall
- Track down the Ideal Weight reduction Methodology for Your Way of life
- A 'rampaging lion' nebula roars to life in a stunning deep-space photo
- Find the Advantages of Innovative Leisure activities: Supporting Creative mind and Self-Articulation
